- Home
- ARCT vs BHR Comparison
ARCT vs BHR Comparison
Compare ARCT & BHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARCT | BHR |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.1M | 159.3M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARCT | BHR |
|---|---|---|
| Price | $5.52 | $2.25 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $24.11 | N/A |
| AVG Volume (30 Days) | 564.0K | ★ 702.4K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 8.47% |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $82,031,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.77 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.74 | $1.88 |
| 52 Week High | $24.14 | $3.19 |
Technical Indicators
Market Signals| Indicator | ARCT | BHR |
|---|---|---|
| Relative Strength Index (RSI) | 26.97 | 58.08 |
| Support Level | N/A | $2.19 |
| Resistance Level | $7.98 | $2.61 |
| Average True Range (ATR) | 0.36 | 0.10 |
| MACD | -0.10 | 0.03 |
| Stochastic Oscillator | 0.23 | 86.57 |
Price Performance
Historical ComparisonAbout ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
About BHR Braemar Hotels & Resorts Inc.
Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury hotels and resorts. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.